Skip to content Skip to sidebar Skip to footer

Censea, Inc. recalls Headless Shell on Black Tiger Shrimp due to possible contamination of Salmonella

LAKELAND, Fla, 2016-Sep-21 — /EPR Retail News/ — Censea, Inc. is recalling its A-PAC 8/12 count Headless Shell on Black Tiger Shrimp, because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.

Product was distributed to wholesale, retail and restaurant locations in NY, NJ, MA, RI, CT, VA, KY, IL and TX.

The recalled product can be identified as follows:

Product Name: 8/12 Headless Shell On Black Tiger Frozen Shrimp
Origin: Vietnam
Case Pack: 6 x 4 pound block frozen (24 pound Master Carton) not labeled for retail sale
Brand: A-PAC
Date Code: 36009V

No other products or date codes are affected.

There have been no illnesses reported as a result of consuming these products to date, and the product is being recalled in an abundance of caution after testing by the Arizona Department of Health Services of this not-ready-to-eat product indicated the presence of Salmonella. Affected shrimp are raw and are must be fully cooked before consumption.

If you are in possession of this product you should discard it, but retain proof of purchase information (such as a purchase receipt or photo of the product packaging) and contact Censea for a full refund.

Contact: We have setup a hotline to deal with this issue. The phone number for the hotline is 888-312-5995 and it is available Monday through Friday 7 AM to 7 PM Central Standard Time. You may also contact Aaron Breen by e-mail at


Recall Hotline

Source: US FDA

EPR Retail News